Express Scripts Will Favor Mylan's EpiPen Over Competitors
Pharmacy benefit manager Express Scripts Holding Co. said it will cover Mylan Inc.'s EpiPen allergy treatment over competing epinephrine auto-injector systems for the 2018 benefit year, according to its list of covered drugs released Monday....To view the full article, register now.
Already a subscriber? Click here to view full article